Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -164.58% is 68% below its 5-year average of -98.10%, near the high end of its 5-year range (-629.78%–-8.26%).
As of the fiscal period ended Thursday, April 30, 2026. 24.28% above its 12-month average of -217.34%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-04-30): -164.58%.
RETURN ON INVESTED CAPITAL (ROIC)
-164.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-217.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-268.44%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-98.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-202.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-116.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-90.10%
CURRENT VS TTM AVG
+24.28%
CURRENT VS 3Y AVG
+38.69%
CURRENT VS 5Y AVG
-67.76%
CURRENT VS 10Y AVG
+18.61%
CURRENT VS 15Y AVG
-41.10%
CURRENT VS 20Y AVG
-82.65%
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-361.71%
vs the sector median at left
BriaCell Therapeutics Corp.
Market Cap
$35.19M
Return on Invested Capital (ROIC)
-164.58%
TTM Avg
-217.34%
3Y Avg
-268.44%
5Y Avg
-98.10%
Market Cap
$35.57M
Return on Invested Capital (ROIC)
-89.44%
TTM Avg
-27.62%
3Y Avg
-11.28%
5Y Avg
-9.71%
Market Cap
$34.42M
Return on Invested Capital (ROIC)
-52.61%
TTM Avg
-25.54%
3Y Avg
-42.13%
5Y Avg
-36.31%
Market Cap
$34.48M
Return on Invested Capital (ROIC)
-79.27%
TTM Avg
-43.87%
3Y Avg
-333.47%
5Y Avg
-212.56%
Market Cap
$35.86M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-107.47%
3Y Avg
-107.47%
5Y Avg
-107.47%
Market Cap
$36.28M
Return on Invested Capital (ROIC)
-22.79%
TTM Avg
-490.24%
3Y Avg
-256.92%
5Y Avg
-224.31%
Market Cap
$36.23M
Return on Invested Capital (ROIC)
-171.36%
TTM Avg
-234.34%
3Y Avg
-204.54%
5Y Avg
-189.00%
Market Cap
$33.71M
Return on Invested Capital (ROIC)
-249.58%
TTM Avg
-1007.23%
3Y Avg
-664.86%
5Y Avg
-535.30%
Market Cap
$33.60M
Return on Invested Capital (ROIC)
-207.97%
TTM Avg
-157.56%
3Y Avg
-117.52%
5Y Avg
-96.17%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BriaCell Therapeutics Corp. (BCTX) | $35.19M | -164.58% | -217.34% | -268.44% | -98.10% |
| DocGo Inc. (DCGO)vs › | $35.57M | -89.44% | -27.62% | -11.28% | -9.71% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.42M | -52.61% | -25.54% | -42.13% | -36.31% |
| Elutia Inc (ELUT)vs › | $34.48M | -79.27% | -43.87% | -333.47% | -212.56% |
| EUDA Health Holdings Limited (EUDA)vs › | $35.86M | N/A | -107.47% | -107.47% | -107.47% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.28M | -22.79% | -490.24% | -256.92% | -224.31% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.23M | -171.36% | -234.34% | -204.54% | -189.00% |
| HeartBeam, Inc. (BEAT)vs › | $33.71M | -249.58% | -1007.23% | -664.86% | -535.30% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.60M | -207.97% | -157.56% | -117.52% | -96.17% |
| Scilex Holding Company (SCLX)vs › | $33.58M | N/A | -121.47% | -115.97% | -115.97% |
ROIC
-164.6%
ROE
-154.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-04-30 | -164.58% |
| 2026-01-31 | -130.77% |
| 2025-10-31 | -437.26% |
| 2025-07-31 | -157.11% |
| 2025-04-30 | -197.01% |
| 2025-01-31 | -629.78% |
| 2024-10-31 | -542.93% |
| 2024-01-31 | -384.47% |
| 2023-10-31 | -147.82% |
| 2023-07-31 | -92.57% |
| 2023-04-30 | -68.60% |
| 2023-01-31 | -53.71% |
| 2022-10-31 | -44.58% |
| 2022-07-31 | -34.02% |
| 2022-04-30 | -24.24% |
| 2022-01-31 | -21.28% |
| 2021-10-31 | -12.30% |
| 2021-07-31 | -8.26% |
| 2021-04-30 | -28.32% |
| 2019-04-30 | -521.90% |
| 2018-10-31 | -372.95% |
| 2018-07-31 | -189.60% |
| 2018-04-30 | -106.61% |
| 2018-01-31 | -663.11% |
| 2017-10-31 | -279.58% |
| 2017-07-31 | -331.85% |
| 2017-04-30 | -111.52% |
| 2017-01-31 | -83.88% |
| 2016-10-31 | -97.40% |
| 2016-07-31 | -193.76% |
| 2016-04-30 | -136.85% |
| 2016-01-31 | -359.21% |
| 2015-10-31 | -357.93% |
| 2015-07-31 | -248.39% |
| 2015-04-30 | -166.34% |
| 2015-01-31 | -146.80% |
| 2014-10-31 | -69.38% |
| 2014-04-30 | -4.52% |
| 2014-01-31 | -4.73% |
| 2013-10-31 | -4.52% |
| 2013-07-31 | -4.66% |
| 2013-04-30 | -11.59% |
| 2013-01-31 | -11.32% |
| 2012-10-31 | -11.54% |
| 2012-07-31 | -11.92% |
| 2012-04-30 | -8.71% |
| 2012-01-31 | -9.82% |
| 2011-10-31 | -10.11% |
| 2011-07-31 | -8.77% |
| 2011-04-30 | -4.01% |
| 2011-01-31 | -34.85% |
| 2010-10-31 | -21.48% |
| 2010-07-31 | -16.99% |
| 2010-04-30 | -21.98% |
| 2010-01-31 | -29.15% |
| 2009-10-31 | -25.88% |
| 2009-07-31 | -23.07% |
| 2009-04-30 | -35.68% |
| 2009-01-31 | -84.75% |
| 2008-10-31 | -67.08% |
| 2008-07-31 | -31.91% |
| 2008-04-30 | -22.52% |
| 2008-01-31 | -17.48% |
| 2007-10-31 | -18.57% |
| 2007-07-31 | -26.79% |
